NCT01486121

Brief Summary

Use of sedatives and analgesics is common in mechanically ventilated patients hospitalized in Intensive Care Unit (ICU). That is called " sedation " and aimed to reduce both pain and anxiety and also to allow an effective and atraumatic mechanical ventilation. However, sedation excess and ventilator support excess, both in duration and intensity, are associated with an excess morbidity. Patients usually are systematically sedated after having been intubated. Then, sedation is stopped first before ventilator support is weaning. Several studies shown that rationalized protocols of sedation and ventilation orderings had a beneficial impact on non surgical patients' outcome. Feasibility of these protocols in surgical patients is still unknown. Moreover, no study has evaluated an optimized paired strategy of sedation-ventilation based on the priority setting of ventilation. This priority setting of ventilation should increase patient's comfort in spite of increasing sedatives and analgesics dosing. An paired sedation-ventilation protocol optimized for both duration and intensity of these treatments could improve surgical patients' outcome in ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P25-P50 for phase_3 surgery

Timeline
Completed

Started Dec 2011

Typical duration for phase_3 surgery

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2011

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 6, 2011

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

December 2, 2015

Status Verified

December 1, 2015

Enrollment Period

3.3 years

First QC Date

November 10, 2011

Last Update Submit

December 1, 2015

Conditions

Keywords

SurgeryCritical illnessMechanical ventilationOrgan dysfunction syndromeIntensive Care Units SedationAnalgesiaTreatment protocolNursing protocolOutcomePainNeurological disordersDeliriumMuscular weaknessPsychological disordersAnxietyDepressionStress disordersPost-Traumatic

Outcome Measures

Primary Outcomes (1)

  • Time to successful intubation

    Time to successful intubation is defined as time from randomization to extubation (or tracheotomy mask) for 48 hours.

    for 48 hours after intubation

Secondary Outcomes (7)

  • Dose and duration of sedation

    Day 0 to Days 28

  • Type and duration of mechanical ventilation

    Day 0 to Days 28

  • Complications acquired in ICU

    Days 28

  • Length of stay in ICU and hospital

    up to 6 months

  • Mortality

    up to 12 months

  • +2 more secondary outcomes

Study Arms (2)

S.O.S.-V

OTHER
Other: Therapy strategy

Standard

NO INTERVENTION

Interventions

Sedation \& mechanical ventilation

S.O.S.-V

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ventilated patient in assist control mode after a surgical procedure expected to be ventilated for 12-hours or more
  • At least 1 organ dysfunction according to SOFA score
  • Non paralyzed because of neuromuscular blocking agents
  • Body temperature \> or equal 36°CAge \> or equal 18
  • Surrogate decision maker's consent

You may not qualify if:

  • Patients without any surgical procedure (medical patients)
  • Continuous mechanical ventilation for 24-hours or longer
  • Hospitalisation in ICU for 7-days or longer
  • Severe ARDS (Acrasis study criteria, New England J Med 2011)
  • Neurological injury
  • Active toxicomania
  • Reduction or cessation of active treatment
  • Patient under tutelage
  • Pregnancy
  • No French health insurance
  • Enrollment in another study on sedation or mechanical ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Anesthesiology & Critical Care, Estaing University Hospital

Clermont-Ferrand, 63000, France

Location

Department of Anesthesiology & Critical Care, St Eloi University Hospital

Montpellier, 34000, France

Location

Department of Anesthesiology & Critical Care, Caremeau University Hospita

Nîmes, 30000, France

Location

Related Publications (1)

  • Chanques G, Conseil M, Roger C, Constantin JM, Prades A, Carr J, Muller L, Jung B, Belafia F, Cisse M, Delay JM, de Jong A, Lefrant JY, Futier E, Mercier G, Molinari N, Jaber S; SOS-Ventilation study investigators. Immediate interruption of sedation compared with usual sedation care in critically ill postoperative patients (SOS-Ventilation): a randomised, parallel-group clinical trial. Lancet Respir Med. 2017 Oct;5(10):795-805. doi: 10.1016/S2213-2600(17)30304-1. Epub 2017 Sep 18.

MeSH Terms

Conditions

Critical IllnessAgnosiaPainNervous System DiseasesDeliriumMuscle WeaknessMental DisordersAnxiety DisordersDepressionStress Disorders, Traumatic

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsConfusionNeurocognitive DisordersMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsBehavioral SymptomsBehaviorTrauma and Stressor Related Disorders

Study Officials

  • Gerald GC Chanques, MD, PhD

    UH, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2011

First Posted

December 6, 2011

Study Start

December 1, 2011

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

December 2, 2015

Record last verified: 2015-12

Locations